Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study.
Marijon E, Trinquart L, Otmani A, Leclercq C, Fauchier L, Chevalier P, Klug D, Defaye P, Lellouche N, Mansourati J, Deharo JC, Sadoul N, Anselme F, Maury P, Davy JM, Extramiana F, Hidden-Lucet F, Probst V, Bordachar P, Mansour H, Chauvin M, Jouven X, Lavergne T, Chatellier G, Le Heuzey JY; EVADEF Investigators.
Marijon E, et al. Among authors: maury p.
Am Heart J. 2010 Apr;159(4):659-664.e1. doi: 10.1016/j.ahj.2010.01.011.
Am Heart J. 2010.
PMID: 20362726
Clinical Trial.